Author | Katherine Krajewski, MD | OncLive

Author | Katherine Krajewski, MD


Dr. Krajewski on Responses With PD-1 Agents in RCC

March 17, 2016


Katherine Krajewski, MD, associate director, physician, Cancer Imaging Program Fellowship, Dana-Farber Cancer Institute, assistant professor of Radiology, Harvard Medical School, discusses the range of responses seen in patients with renal cell carcinoma (RCC) who have received PD-1 agents as treatment.